PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Memantine hydrochloride (Dementia)
Presentation Product Chemical substance Chapter Items dispensed
Memantine 20mg tablets
0411000G0AAADAD
Memantine hydrochloride (Dementia) Memantine hydrochloride Central Nervous System 258,410
Memantine 10mg tablets
0411000G0AAAAAA
Memantine hydrochloride (Dementia) Memantine hydrochloride Central Nervous System 140,482
Memantine 10mg/ml oral solution sugar free
0411000G0AAABAB
Memantine hydrochloride (Dementia) Memantine hydrochloride Central Nervous System 24,936
Memantine 20mg orodispersible tablets sugar free
0411000G0AAAGAG
Memantine hydrochloride (Dementia) Memantine hydrochloride Central Nervous System 7,392
Memantine 10mg orodispersible tablets sugar free
0411000G0AAAFAF
Memantine hydrochloride (Dementia) Memantine hydrochloride Central Nervous System 3,928
Memantine 5mg/10mg/15mg/20mg tabs treatment initiation pack
0411000G0AAAEAE
Memantine hydrochloride (Dementia) Memantine hydrochloride Central Nervous System 3,045
Memantine 5mg orodispersible tablets sugar free
0411000G0AAAKAK
Memantine hydrochloride (Dementia) Memantine hydrochloride Central Nervous System 1,631
Memantine 5mg/10mg/15mg/20mg orodispersible initiation pack
0411000G0AAAJAJ
Memantine hydrochloride (Dementia) Memantine hydrochloride Central Nervous System 217
Memantine 20mg soluble tablets sugar free
0411000G0AAAIAI
Memantine hydrochloride (Dementia) Memantine hydrochloride Central Nervous System 188
Memantine 10mg soluble tablets sugar free
0411000G0AAAHAH
Memantine hydrochloride (Dementia) Memantine hydrochloride Central Nervous System 125

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.